why choose us

First received: January 24, 2023

Clinical Trial: HEPA, PM2.5, and Cardiometabolic Health

Study Status: Completed

Recruit Status: RECRUITING

Condition: Air Pollution

Study Type: INTERVENTIONAL


Official Title: Using Indoor Air Filtration to Reduce PM2.5 Cardiometabolic Effects in At-risk Individuals

Brief Summary: The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.

Read more